(Q51036130)

27 March 2018

title

Effect of quinapril or metoprolol on heart rate variability in post-myocardial infarction patients. (English)

1 reference

27 March 2018

main subject

heart rate variability

0 references

myocardial infarction

1 reference

2

1 reference

27 March 2018

author name string

Kontopoulos AG

1

1 reference

27 March 2018

Papageorgiou AA

3

1 reference

27 March 2018

Papadopoulos GV

4

1 reference

27 March 2018

Avramidis MJ

5

1 reference

27 March 2018

Boudoulas H

6

1 reference

27 March 2018

language of work or name

English

0 references

publication date

1 February 1996

1 reference

27 March 2018

American Journal of Cardiology

published in

1 reference

27 March 2018

volume

77

1 reference

27 March 2018

issue

4

1 reference

27 March 2018

page(s)

242-246

1 reference

27 March 2018

cites work

Heart rate variability

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989386-1

Prognostic value of reduced heart rate variability after myocardial infarction: clinical evaluation of a new analysis method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989386-1

Comparison of the predictive characteristics of heart rate variability index and left ventricular ejection fraction for all-cause mortality, arrhythmic events and sudden death after acute myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989386-1

Risk stratification for arrhythmic events in postinfarction patients based on heart rate variability, ambulatory electrocardiographic variables and the signal-averaged electrocardiogram.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989386-1

Decreased heart rate variability and its association with increased mortality after acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989386-1

Effects of beta blockers (atenolol or metoprolol) on heart rate variability after acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989386-1

Left ventricular mass and systolic performance in chronic systemic hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989386-1

Heart rate variability as an index of sympathovagal interaction after acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989386-1

Time course of recovery of heart period variability after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989386-1

Effects of autonomic blockade on the baroreflex in man at rest and during exercise.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989386-1

Effects of propranolol on the impulse activity of cardiovascular sympathetic afferent fibers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989386-1

Effect of atenolol and diltiazem on heart period variability in normal persons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989386-1

Effect of Beta-blockade on heart rate variability in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989386-1

Relation between heart rate variability early after acute myocardial infarction and long-term mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989386-1

Influence of captopril on the arterial baroreceptor reflex in patients with heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989386-1

ACE inhibition improves vagal reactivity in patients with heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989386-1

Evidence of parasympathetic activity of the angiotensin converting enzyme inhibitor, captopril, in normotensive man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989386-1

A placebo-controlled trial of captopril in refractory chronic congestive heart failure. Captopril Multicenter Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989386-1

Effect of quinapril on blood pressure and heart rate in congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989386-1

Sustained augmentation of parasympathetic tone with angiotensin-converting enzyme inhibition in patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989386-1

Lymphocyte beta adrenoceptor upregulation and improved cardiac response to adrenergic stimulation following converting enzyme inhibition in congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989386-1

Hypersensitivity to Adrenergic Stimulation after Propranolol Withdrawal in Normal Subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989386-1

Increased beta-receptor density and improved hemodynamic response to catecholamine stimulation during long-term metoprolol therapy in heart failure from dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989386-1

10.1016/S0002-9149(97)89386-1

7 January 2021

Identifiers

DOI

1 reference

27 March 2018

PubMed ID

8607401

1 reference

27 March 2018